Imipramine Hydrochloride USP For Compounding (API)

Imipramine Hydrochloride USP is an active pharmaceutical ingredient (API) used in the treatment of major depression, nocturnal enuresis (bedwetting), and insomnia. It belongs to the class of tricyclic antidepressants (TCAs) and works by increasing the levels of certain neurotransmitters (chemical messengers) in the brain, such as serotonin and norepinephrine. These neurotransmitters are involved in regulating mood, emotions, and sleep cycles, which helps improve symptoms of depression and other disorders. Imipramine hydrochloride can help improve mood, increase energy levels, reduce anxiety, and improve sleep quality. This API is available in various forms including tablets, capsules, and oral solutions, and is often used in combination with other medications or therapies as part of a comprehensive treatment plan.

Imipramine Hydrochloride USP is a medication that is primarily used to treat major depressive disorder. It belongs to a class of drugs called tricyclic antidepressants. When used for compounding, it is typically used to create customized formulations for specific patients who may have difficulty taking commercially available formulations, such as those who are allergic to certain ingredients or have trouble swallowing pills. It may also be used for off-label purposes, such as to treat other psychiatric conditions or chronic pain. It should only be used under the supervision of a healthcare provider.

CAS Number: 113-52-0

Property: Light Sensitive